Differential Synergy of Notch and T Cell Receptor Signaling Determines Αβ

Total Page:16

File Type:pdf, Size:1020Kb

Differential Synergy of Notch and T Cell Receptor Signaling Determines Αβ ARTICLE Diff erential synergy of Notch and T cell receptor signaling determines αβ versus γδ lineage fate Annette I. Garbe,1 Andreas Krueger,1 Fotini Gounari,1,2 Juan Carlos Zúñiga-Pfl ücker,3 and Harald von Boehmer1 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115 2Tufts-New England Medical Center, Boston, MA 02111 3University of Toronto, Toronto, Ontario, M4N 3M5 Canada Thymic precursors expressing the pre–T cell receptor (TCR), the TCR, or the TCR can all enter the CD4+8+ lineage, albeit with different effi cacy. Here it is shown that proliferation and differentiation of precursors with the different TCRs into lineage cells require Notch signaling at the DN3 stage of thymic development. At the DN4 stage, Notch signaling still signifi cantly contributes to the generation of T cells. In particular, in lineage commitment, the pre-TCR synergizes more effi ciently with Notch signals than the other two TCRs, whereas TCR-expressing cells can survive and expand in the absence of Notch signals, even though Notch signaling enhances their proliferation. These observations suggest a new model of versus lineage choice in which lineage fate is determined by the extent of synergy between TCR and Notch signaling and in which the evolutionarily recent advent of the cell-autonomously signaling pre-TCR increased the effi cacy of T cell generation. CORRESPONDENCE The mammalian immune system contains sev- essential for the rescue of DP cells from pro- Harald von Boehmer: eral T lymphocyte lineages of which the grammed cell death, which requires binding Harald_von_Boehmer@ αβTCR lineage and the γδTCR lineage di- with relatively low avidity to intrathymic dfci.harvard.edu verge relatively early in T lymphocyte devel- MHC ligands and results in the generation of + + + + Abbreviations used: DL-1, opment, resulting in CD4 /8 cells expressing CD4 helper and CD8 cytolytic T cells de- Delta-like 1; DN, double nega- an αβTCR and CD4−8− double negative (DN) pending on the binding of the αβTCR to class tive; DP, double positive; GSI, γδ γ-secretase inhibitor; pTα, cells with a TCR. II and class I MHC molecules, respectively pre-TCRα. The gene segments encoding the γδTCR (8–10). This binding also results in termination rearrange slightly before or at the same time as of Ptcra gene transcription (11). The Journal of Experimental Medicine the Tcrb v-gene segments that encode the Although the above scenario represents the TCRβ chain. T cells expressing the αβ T cell most eff ective pathway of generating αβ lin- receptor develop from precursors that fi rst re- eage cells, it does not represent the only one. arrange the Tcrb locus (1, 2) and express TCRβ In Ptcra knockout mice, it was found that not chains in association with the invariant pre- only the pre-TCR but also γδTCRs or some TCRα (pTα) chain (3, 4). The pre-TCR is prematurely expressed αβTCRs in DN3 cells required for the rescue of CD25+44− (DN3) could rescue the generation of bona fi de αβ cells from programmed cell death (5) and is es- lineage cells (12): Ptcra−/− Tcrd−/− mice are un- sential for extensive proliferation of the rescued able to make either the pre-TCR or the cells that eventually become CD4+CD8+ dou- γδTCR. In these mice, it was shown that pre- ble positive (DP) cells that rearrange the Tcra maturely expressed αβTCRs could rescue αβ locus (6). TCRα chains when compared with T cell development by facilitating the genera- the pTα chain compete favorably for covalent tion of DP cells that all contained productively pairing with the TCRβ chain (7), resulting in rearranged TCRβ chains (12). In Ptcra−/− expression of the αβTCR. The αβTCR is Tcra−/− mice, γδTCRs could rescue the devel- opment of αβ lineage DP cells of which only A.I. Garbe and A. Krueger contributed equally to this work. 15% expressed TCRβ chains in the cytoplasm The online version of this article contains supplemental material. (12). The latter observation is well in line with JEM © The Rockefeller University Press $8.00 1579 Vol. 203, No. 6, June 12, 2006 1579–1590 www.jem.org/cgi/doi/10.1084/jem.20060474 data showing that in pre-TCR–defi cient mice, such as mitment (16), whereas elimination of the Notch-dependent Ptcra−/− and Tcrb−/− mice, γδTCR-expressing cells can enter transcription factor CSL (RBP-Jκ) at a later stage was asso- the αβ lineage, abolish γδTCR expression, and rearrange ciated with impairment of αβ lineage development (17). the Tcra locus (12, 13). However, only a fraction of (DN) Again, the latter in vivo experiments did not establish cells with αβTCRs or γδTCRs become αβ lineage DP cells whether Notch contributed to the survival and/or prolifer- because many of the DN cells expressing a γδTCR or ation of cells after lineage commitment or whether it was αβTCR become functionally mature CD4−8− cells in which directly involved in lineage commitment. This question TCR ligation results in cytokine secretion (13, 14). Such was analyzed in more detail in a recently developed culture functionally mature CD4−8− cells, however, are not found system, which revealed that Notch receptor Delta-like 1 among pre-TCR–expressing cells. These experiments sug- (DL-1) ligands were required for early T lineage commit- gest that the type of TCR expressed in immature precursors ment as well as diff erentiation of CD44+25− (DN1) cells can contribute to lineage choice but that in all likelihood into CD44+25+ (DN2) and CD25+44− (DN3) cells, repre- other factors have a decisive role as well. Here we have asked senting sequential steps of development before TCR ex- in which way can DN3 precursor cells that do not express the pression (18). Also, at the DN3 stage, pre-TCR–expressing pre-TCR, i.e., DN3 cells with γδTCRs or αβTCRs, enter cells required Notch ligands to further develop into αβ the αβ lineage. lineage cells (19). By analysis of DN3 cells from RAG- In the context of these questions, it is of interest that defi cient mice that are unable to rearrange TCR loci, it was experiments addressing the role of Notch in αβ versus γδ T found that DL-1 ligands contributed a survival signal at this cell lineage decision concluded that higher levels of Notch1 checkpoint (20). receptors on T cell precursors favored the development of Here we have investigated whether Notch contributes to αβ lineage over γδ lineage cells under conditions where the entry into the αβ lineage of pre-TCR–, γδTCR-, and Notch1+/+ cells were competing with Notch1+/− precursors αβTCR-expressing precursors at the DN3 stage of develop- and in which more αβ lineage cells had the Notch1+/+ than ment and whether there is diff erential synergy of Notch sig- the Notch1+/− genotype (15). It was not clear from these nals with signals generated by diff erent TCRs. To this end, data whether Notch favored survival and/or proliferation of we cultured DN3 cells from mice that can express various committed αβ lineage precursors or whether Notch signal- TCRs in the presence or absence of Notch DL-1 ligands and ing was required for αβ lineage choice. Subsequent studies have quantitated the requirement for Notch signals by in- concerning the role of Notch in T cell development using hibiting Notch signaling with a γ-secretase inhibitor (GSI). knockout strategies revealed that Notch signaling played an Furthermore, we analyzed whether Notch signaling contributes essential role at an earlier stage in T versus B lineage com- to the proliferation and diff erentiation of cells at the DN4 Figure 1. Phenotype of mice with different TCRs. Thymocytes from TCRγδ transgenic mice on the Rag-1−/− background (TCRγδ), and lck-pTα transgenic mice on the Ptcra−/− background (lck-pTα), Ptcra−/− RAG-1−/− mice (Rag−/−) were stained with CD4, CD8, TCRγδ, and TCRβ mice (pTα−/−), lck-TCRα mice on the Ptcra−/− background (lck-TCRα), antibodies. Numbers in each quadrant indicate the percentage of cells. 1580 NOTCH AND TCR SIGNALING IN LINEAGE COMMITMENT | Garbe et al. ARTICLE stage of development. The fi ndings suggest a novel model of timing of receptor expression is equivalent to that seen in αβ T cell lineage commitment in which the extent of syn- normal mice. The γδTCR transgenic mice express the ergy between Notch signaling and TCR signaling determines transgenic TCR at the DN4 stage of development as it oc- lineage fate and in which diff erent TCRs make a defi nite curs in normal mice. Fig. 1 shows the phenotypic analysis contribution to lineage choice. of thymuses from these mice. Introduction of the pTα chain under the lck promoter into Ptcra−/− mice results in RESULTS a normal thymic phenotype, with DP cells representing Phenotype of mice with different TCRs the vast majority of cells and a minor fraction of DN To study the impact of diff erent TCRs on lineage devel- γδTCR- or αβTCR-expressing cells (21). Ptcra−/− mice opment, we used the following mice: fi rst, lck-pTα trans- have few DP cells and mostly DN γδTCR- and fewer genic mice on the Ptcra−/− background that can mostly DN αβTCR-expressing cells. Lck-TCRα mice on the produce the pre-TCR as well as diverse γδTCRs and few Ptcra−/− background have a smaller proportion of DP cells diverse αβTCRs; second, Ptcra−/− mice that cannot make than lck-pTα mice and an increased proportion of DN the pre-TCR but do make diverse γδTCRs and a few cells expressing γδTCRs and αβTCRs. TCRγδ trans- αβTCRs by rearrangement of endogenous genes; third, genic Rag-1−/− mice have DP cells, some of which express lck-TCRα mice on the Ptcra−/− background that instead low levels of the transgenic TCR, and few DN cells with of the pre-TCR express diverse αβTCRs at an early stage low levels of the γδTCR when compared with γδ T cells of development, exaggerating the few DN cells that ex- from Ptcra−/− mice.
Recommended publications
  • Deciphering Thymic Development
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE OPINION ARTICLE published: 08provided October by 2014 Frontiers - Publisher Connector doi: 10.3389/fimmu.2014.00424 Deciphering thymic development Harald Von Boehmer 1,2* 1 Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA 2 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA, USA *Correspondence: [email protected] Edited by: Kendall A. Smith, Weill Medical College of Cornell University, USA Reviewed by: Herman Waldmann, University of Oxford, UK Keywords: MHC-restricted antigen recognition, T cell clones, TCR alpha/beta cDNA clones, HY antigen, TCR transgenic mice, negative thymic selection, positive thymic selection In 1979, some of us were surprised by beta genes from one T cell clone to asked Hans Georg Rammensee who was the (1) conclusion of Doherty and Zinker- another allowed us to unequivocally con- in the same office a related question. I nagel on MHC-restricted antigen recogni- clude that the MHC-restricted specificity leave it to the audience to imagine what tion following the lead of Katz, Hamaoka, was encoded by a single receptor long Michael Steinmetz told Georges Koehler and Benacerraf (2) describing the same before crystallographic studies reached or better what he did not tell him, even for the interaction of T helper cells with the same conclusion (5). This surprised though one cannot be completely sure of B cells as well as Rosenthal and Shevach some molecular biologists somewhat who it. So Georges did not produce the mice (3) describing it for the interaction of T thought that the cloning of the TCR put but Anton Berns in Amsterdam cooper- cells with macrophages.
    [Show full text]
  • Table of Contents
    Cancer Immunology Research Table of Contents July 2014 Volume 2 Issue 7 EDITORIAL RESEARCH ARTICLES 591 Cancer Immunology Research: A One-Year 616 Immunotherapy Converts Nonimmunogenic Anniversary Pancreatic Tumors into Immunogenic Foci of Immune Regulation Eric R. Lutz, Annie A. Wu, Elaine Bigelow, Rajni Sharma, Guanglan Mo, Kevin Soares, Sara Solt, MASTERS OF IMMUNOLOGY Alvin Dorman, Anthony Wamwea, Allison Yager, Daniel Laheru, Christopher L. Wolfgang, 592 The Thymus in Immunity and in Malignancy Jiang Wang, Ralph H. Hruban, Robert A. Anders, Harald von Boehmer Elizabeth M. Jaffee, and Lei Zheng Synopsis: Lutz and colleagues show that an allogeneic vaccine given with or without low-dose cyclophosphamide converted pancreatic cancer into an immunogenic cancer CANCER IMMUNOLOGY AT THE with infiltrating effector lymphocytes and formation of CROSSROADS: EXPERIMENTAL tertiary lymphoid aggregates that are regulatory structures IMMUNOTHERAPIES of adaptive immunity. 632 598 Hostile, Hypoxia–A2-Adenosinergic Tumor Bevacizumab plus Ipilimumab in Patients with Biology as the Next Barrier to Overcome for Metastatic Melanoma Tumor Immunologists F. Stephen Hodi, Donald Lawrence, Cecilia Lezcano, Xinqi Wu, Jun Zhou, Tetsuro Sasada, Wanyong Zeng, Michail V. Sitkovsky, Stephen Hatfield, Anita Giobbie-Hurder, Michael B. Atkins, Robert Abbott, Bryan Belikoff, Dmitriy Lukashev, Nageatte Ibrahim, Philip Friedlander, and Akio Ohta Keith T. Flaherty, George F. Murphy, Scott Rodig, Elsa F. Velazquez, Martin C. Mihm Jr, Sara Russell, MILESTONES IN CANCER
    [Show full text]
  • April 8, 1997, NIH Record, Vol. XLIX, No. 7
    C 0 R a Still The Second Best Thing About Payday Record Debuts on the Web HIGHLIGHTS· From 'Whatchamacallit' to Funshine New Camp Starts for Children The NIH Record, exclusively a paper publication since May 1949, is now Special love Infected with HIV available electronically on the World Wide launches New By Rich McManus Web. It can be accessed within the NIH Camp home page (www.nih.gov) under the nless you just came to NIH a week ago, you probably know at " Information for Employees" and "News Microsoft least something about Camp Fantastic. For the uninitiated, it's and Events" sections. Or open the site Wunderkind ~ a week-long slice of August turned into terrific summer camp directly by going to http://www.nih.gov/ Foretells Future for children-many of them Clinical Center patients-with cancer, news/NIH-Record/archives.htm. and has always been powered by the freehearted and funloving Catch the Record side of the National Cancer Institute-its Pediatric Branch and The Web version is modeled after the on the Web associated caregivers. It began 15 years ago at a 4-H campground paper one and closely resembles it, but has near Front Royal, Va., and has evolved into a year-round, family­ the advantage of color design and centered program that worries not just about the child with photography. The site's opening page is an cancer, but also about the healthy sibling who wonders where all " Archives" of issues that leads off-for the Dyer, Gorgas Talks of mom and dad's attention went.
    [Show full text]
  • Shaping the T Cell Repertoire
    Shaping the T Cell Repertoire Harald von Boehmer J Immunol 2005; 175:7067-7068; ; This information is current as doi: 10.4049/jimmunol.175.11.7067 of September 27, 2021. http://www.jimmunol.org/content/175/11/7067 Downloaded from References This article cites 6 articles, 3 of which you can access for free at: http://www.jimmunol.org/content/175/11/7067.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 27, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts Errata An erratum has been published regarding this article. Please see next page or: /content/176/1/677.1.full.pdf /content/176/1/677.2.full.pdf The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Shaping the T Cell Repertoire Harald von Boehmer1 Today immunologists are well aware of positive to self. In this hypothesis, the focus on self-MHC was imposed and negative selection of developing T cells.
    [Show full text]
  • Harald Von Boehmer 1942–2018
    obituary Harald von Boehmer 1942–2018 oday, few topics in immunology Notch family of signaling receptors in this receive more attention than efforts malignancy. With colleagues in the lab, Tto detect, induce or reinvigorate the Harald also published important insights immune response to tumors. Although into the mechanisms through which many types of immune cells affect different T cell populations respond to and contribute to anti-tumor immune tumors and destroy pancreatic β -cells. At responses, the initial clinical findings that the same time, he never stopped pursuing electrified the field focused on the T cell. knowledge of the basic mechanisms that Cancer biologists who grabbed the nearest affect T cell development. While in Boston, immunology textbook in an effort to fully his lab described mechanisms that affect comprehend and build upon those initial the development of regulatory T cells in the clinical successes will have quickly realized thymus and the periphery and continued that at their core, such approaches rely on to publish insights into the structure and understanding how T cells recognize and function of the pre-TCR. respond to antigen. What they may not After closing his Boston lab, Harald have realized is how important Harald returned to his alma mater as a guest von Boehmer’s work was in laying the professor at the Institute for Immunology foundation for this understanding. of the Ludwig Maximilian University in Long before translational research was Munich. In his writings during this period, all the rage, Harald charged a segment of between the TCR and peptide–major Harald expressed optimism about the future his lab with investigating how fundamental histocompatibility complex determined of immunological research.
    [Show full text]
  • Deciphering Thymic Development
    Deciphering Thymic Development The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Von Boehmer, Harald. 2014. “Deciphering Thymic Development.” Frontiers in Immunology 5 (1): 424. doi:10.3389/fimmu.2014.00424. http://dx.doi.org/10.3389/fimmu.2014.00424. Published Version doi:10.3389/fimmu.2014.00424 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:13347532 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA OPINION ARTICLE published: 08 October 2014 doi: 10.3389/fimmu.2014.00424 Deciphering thymic development Harald Von Boehmer 1,2* 1 Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA 2 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA, USA *Correspondence: [email protected] Edited by: Kendall A. Smith, Weill Medical College of Cornell University, USA Reviewed by: Herman Waldmann, University of Oxford, UK Keywords: MHC-restricted antigen recognition, T cell clones, TCR alpha/beta cDNA clones, HY antigen, TCR transgenic mice, negative thymic selection, positive thymic selection In 1979, some of us were surprised by beta genes from one T cell clone to asked Hans Georg Rammensee who was the (1) conclusion of Doherty and Zinker- another allowed us to unequivocally con- in the same office a related question. I nagel on MHC-restricted antigen recogni- clude that the MHC-restricted specificity leave it to the audience to imagine what tion following the lead of Katz, Hamaoka, was encoded by a single receptor long Michael Steinmetz told Georges Koehler and Benacerraf (2) describing the same before crystallographic studies reached or better what he did not tell him, even for the interaction of T helper cells with the same conclusion (5).
    [Show full text]
  • The Henry Kunkel Society Annual Meeting: Infectious Disease Susceptibility and the Expanding Universe of Primary Immunodeficiency
    The Henry Kunkel Society Annual Meeting: Infectious Disease Susceptibility and the Expanding Universe of Primary Immunodeficiency The Rockefeller University New York, NY April 17–20, 2013 Henry George Kunkel 1916–1983 enry Kunkel received his B.S. degree from Princeton and his M.D. degree from Johns Hopkins University. He arrived at The Rockefeller Institute (now University) in 1945 where he spent his entire scientific career H until his death in 1983. His contributions to the field of basic and clinical immunology are legendary. He made numerous seminal observations in liver disease, rheumatic diseases and other allied disorders. He was perhaps best known for his pioneering and extensive studies on the immunoglobulins. His recognition that myeloma proteins were a model for the study of the structure of normal immunoglobulins had a global impact on investigations of the structure, function and inheritance of these molecules. The elucidation of the chain structure of gamma globulin and the recognition that immunoglobulins possessed individual antigenic specificity (idiotypes) were internationally recognized discoveries. Dr. Kunkel was the recipient of many awards and honors, including membership in the National Academy of Sciences, honorary degrees from Universities of Uppsala and Harvard, and recipient of the Lasker and Gairdner Awards and the Kovalenko Medal of the National Academy of Sciences. Henry Kunkel Society Officers Henry Kunkel Society Lecturers President ................Westley Reeves 1992. Louis Kunkel 2003. .Fred Rosen Vice President ...............Keith Elkon 1993. .David Ho 2004. .Diane Mathis Secretary ........... Michel Nussenzweig 1994. Benvenuto Pernis 2005. Charles Weissman Treasurer ...............Anne Marshak- 1996. Jeffrey Ravetch 2006. Ralph M. Steinman Rothstein 1997. Anthony Fauci 2007.
    [Show full text]
  • The Paul Ehrlich Foundation
    The Paul Ehrlich Foundation Office of the Paul Ehrlich Foundation Contents Paul Ehrlich-Stiftung c/o Vereinigung von Freunden und Förderern der Goethe-Universität Theodor-W.-Adorno-Platz 1 Preface 5 60629 Frankfurt am Main E-Mail: [email protected] www.paul-ehrlich-stiftung.de Paul Ehrlich: His Life March 2021 and Achievements 6 Ludwig Darmstaedter: Donation account: Scientist and Friend 12 Deutsche Bank AG IBAN: DE38 5007 0010 0700 0839 00 BIC: DEUTDEFFXXX The Foundation, the Prize and the Role of Hedwig Ehrlich 14 The Paul Ehrlich and Ludwig Darmstaedter Prize for Young Researchers 17 Preface In honor of the great German doctor and Paul Ehrlich, like all great researchers, was serologist who turned Frankfurt into a way ahead of his time. His research work medical eldorado at the beginning of the laid the cornerstone for the medical stand- 20th century, the Paul Ehrlich and Ludwig ards still valid today. In awarding the Paul Darmstaedter Prize is awarded to scientists Ehrlich and Ludwig Darmstaedter Prize, the from all over the world who have achieved Foundation wishes to encourage scientists all outstanding results in Paul Ehrlich’s field over the world to do what Paul Ehrlich did of work. throughout his entire life: extend medical know-how and make a contribution to the The prize given by the Paul Ehrlich constant struggle against illness and disease- Foundation is one of Germany’s most emi- induced mortality. nent accolades in recognition of outstand- ing achievements in biomedical research. The President of the German Research Foundation (DFG) is Honorary President of the Paul Ehrlich Foundation.
    [Show full text]
  • Immunology in Germany German Society for Immunology
    1901 1984 Emil von Behring Georges J.F. Köhler Nobelprize ‘for his work on serum Nobelprize therapy, especially its ‘for theories application against concerning the diphtheria, by which specificity in 2008 he has opened a new 1905 development and Harald zur road in the domain of Robert Koch control of the Hausen medical science and 1908 immune system thereby placed in the Nobelprize Paul Ehrlich and the discovery Nobelprize hands of the physician ‘for his investigations of the principle ‘for his discovery of a victorious weapon and discoveries in Nobelprize for production human papilloma against illness and relation to ‘in recognition of his of monoclonal viruses causing deaths’ tuberculosis’ work on immunity’ antibodies’ cervical cancer’ Immunology in Germany German Society for Immunology Content Preface ............................................................................... 3 About the DGfI ...................................................................4 Academy of Immunology ...................................................6 Research Focus Groups ......................................................7 Scientific Awards ................................................................8 Annual Meeting ...............................................................10 International Networks & Bilateral Meetings ..................11 Immunology in Germany - Overview ..............................12 Public Outreach - ‚Immunology for Everyone‘ ................16 Membership in the DGfI? Yes! .........................................17
    [Show full text]
  • How Does the Immune System Learn to Distinguish Between Good and Evil? the First Definitive Studies of T Cell Central Tolerance and Positive Selection
    Immunogenetics (2019) 71:513–518 https://doi.org/10.1007/s00251-019-01127-8 REVIEW How does the immune system learn to distinguish between good and evil? The first definitive studies of T cell central tolerance and positive selection Paweł Kisielow1 Received: 30 July 2019 /Accepted: 3 August 2019/Published online: 15 August 2019 # The Author(s) 2019 Abstract Demonstration that immature CD4 + 8+ thymocytes contain T cell precursors that are subjected to positive and negative selection was the major step towards understanding how the adaptive immune system acquires the ability to distinguish foreign or abnormal (mutated or infected) self-cells from normal (healthy) cells. In the present review, the roles of TCR, CD4, CD8, and MHC molecules in intrathymic selection and some of the crucial experiments that contributed to the solution of the great immunological puzzle of self/ nonself discrimination are described in an historical perspective. Recently, these experiments were highlighted by the immunological community by awarding the 2016 Novartis Prize for Immunology to Philippa Marrack, John Kappler, and Harald von Boehmer. Keywords Tcells . Positive and negative selection . Self/nonself discrimination Introduction 1959; Peter Medawar, 1960; Gerald Edelman and Roney Porter, 1972; Baruj Benaceraff, Jean Dausset, and George The “Good” that is protected by the immune system consists Snell, 1983; Niels Jerne, George Koehler, and Cesar Milstein of properly functioning healthy cells, and the “Evil” that is 1984; Susumu Tonegawa, 1987; Peter Doherty
    [Show full text]
  • Table of Contents (PDF)
    Cancer Immunology Research Table of Contents July 2014 Volume 2 Issue 7 EDITORIAL RESEARCH ARTICLES 591 Cancer Immunology Research: A One-Year 616 Immunotherapy Converts Nonimmunogenic Anniversary Pancreatic Tumors into Immunogenic Foci of Immune Regulation Eric R. Lutz, Annie A. Wu, Elaine Bigelow, Rajni Sharma, Guanglan Mo, Kevin Soares, Sara Solt, MASTERS OF IMMUNOLOGY Alvin Dorman, Anthony Wamwea, Allison Yager, Daniel Laheru, Christopher L. Wolfgang, 592 The Thymus in Immunity and in Malignancy Jiang Wang, Ralph H. Hruban, Robert A. Anders, Harald von Boehmer Elizabeth M. Jaffee, and Lei Zheng Synopsis: Lutz and colleagues show that an allogeneic vaccine given with or without low-dose cyclophosphamide converted pancreatic cancer into an immunogenic cancer CANCER IMMUNOLOGY AT THE with infiltrating effector lymphocytes and formation of CROSSROADS: EXPERIMENTAL tertiary lymphoid aggregates that are regulatory structures IMMUNOTHERAPIES of adaptive immunity. 632 598 Hostile, Hypoxia–A2-Adenosinergic Tumor Bevacizumab plus Ipilimumab in Patients with Biology as the Next Barrier to Overcome for Metastatic Melanoma Tumor Immunologists F. Stephen Hodi, Donald Lawrence, Cecilia Lezcano, Xinqi Wu, Jun Zhou, Tetsuro Sasada, Wanyong Zeng, Michail V. Sitkovsky, Stephen Hatfield, Anita Giobbie-Hurder, Michael B. Atkins, Robert Abbott, Bryan Belikoff, Dmitriy Lukashev, Nageatte Ibrahim, Philip Friedlander, and Akio Ohta Keith T. Flaherty, George F. Murphy, Scott Rodig, Elsa F. Velazquez, Martin C. Mihm Jr, Sara Russell, MILESTONES IN CANCER
    [Show full text]
  • Shaping the T Cell Repertoire Harald Von Boehmer J Immunol 2006; 176:3-4; ; This Information Is Current As Doi: 10.4049/Jimmunol.176.1.3 of September 28, 2021
    Shaping the T Cell Repertoire Harald von Boehmer J Immunol 2006; 176:3-4; ; This information is current as doi: 10.4049/jimmunol.176.1.3 of September 28, 2021. http://www.jimmunol.org/content/176/1/3 Downloaded from References This article cites 6 articles, 2 of which you can access for free at: http://www.jimmunol.org/content/176/1/3.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 28, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2006 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Shaping the T Cell Repertoire1 Harald von Boehmer2 Today immunologists are well aware of positive lected by self-MHC molecules in the thymus would proliferate and negative selection of developing T cells. This and mutate their receptors such that they would preferentially was very different almost three decades ago when recognize “altered-self” MHC molecules, which were “similar” MHC-restricted Ag recognition by T cells repre- to self.
    [Show full text]